DXS International (STU:7EE) Inventories, Work In Process: €0.00 Mil (As of Apr. 2025)


STU:7EE DXS International PLC STU:7EE
39 GF Score
Price €0.01
GF Value €0.02
! 2 Warning Signs
View Full Analysis

What is DXS International Inventories, Work In Process?

DXS International STU:7EE 39 Inventories, Work In Process is €0.00 Mil as of Apr. 2025. GuruFocus rates STU:7EE with a GF Score™ of 39/100 and a GF Value™ of €0.02. The stock has 2 warning signs investors should review.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. DXS International's work in process for the quarter that ended in Apr. 2025 was €0.00 Mil.

DXS International Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for DXS International's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DXS International Inventories, Work In Process Chart

DXS International Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Inventories, Work In Process
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

DXS International Semi-Annual Data
Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Inventories, Work In Process Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STU:7EE
39GF Score
DXS International PLC STU:7EE
Inventories, Work In Process is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DXS International Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of €0.00 Mil mean?
DXS International (STU:7EE) has a Inventories, Work In Process of €0.00 Mil as of Apr. 2025. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on DXS International and its competitors.
Is DXS International's Inventories, Work In Process too high?
DXS International's current Inventories, Work In Process is €0.00 Mil. Overall, DXS International has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does DXS International's Inventories, Work In Process compare to VEEV and BTSG?
DXS International's Inventories, Work In Process of €0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Healthcare Providers & Services company?
A good Inventories, Work In Process depends on the Healthcare Providers & Services industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on DXS International and its competitors. DXS International's current Inventories, Work In Process is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DXS International stock overvalued right now?
DXS International (STU:7EE) has a current Inventories, Work In Process of €0.00 Mil. The stock's GF Value™ is €0.02, compared to a current price of €0.01 — trading 45% below its estimated fair value. The current Inventories, Work In Process is €0.00 Mil. DXS International's overall GF Score™ is 39/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For DXS International (STU:7EE), the current Inventories, Work In Process is €0.00 Mil as of Apr. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DXS International (STU:7EE) Overvalued in 2026?

Based on GuruFocus' analysis, DXS International stock appears to be undervalued. The current stock price of €0.01 is trading 45% below its estimated GF Value™ of €0.02.

Key valuation signals for STU:7EE:

  • Inventories, Work In Process: €0.00 Mil
  • GF Value™: €0.02 vs. price of €0.01 (45% below fair value)
  • GF Score™: 39/100 with 2 warning signs

No single metric tells the full story. See the STU:7EE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DXS International Business Description

Other Exchanges DXSP:UK
Address 119 Saint Mary’s Road, Market Harborough, London, Leicestershire, GBR, LE16 7DT
DXS International PLC is engaged in the development and distribution of clinical decision support systems for General Practitioners, nurses, and retail pharmacies in the United Kingdom and South Africa. Its commercial activities include licensing DXS products to various ICBs, offering e-detailing opportunities to the pharmaceutical industry and the UK primary care sector, and licensing its technology to healthcare publishers. The company's products include BestPathway and Point-of-Care ExpertCare.
39GF Score

Get the complete analysis for STU:7EE

Inventories, Work In Process is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.01
Price
€0.02
GF Value